Ernexa Therapeutics Inc. Cash
Ernexa Therapeutics Inc. (ERNA) had Cash of $5.03 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-06
- 2026-06-30: Cash $5.03M.
- 2026-03-31: Cash $9.18M.
- 2025-12-31: Cash $1.88M.
- 2025-09-30: Cash $3.05M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2026-06-30 | $5.03M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $9.18M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $1.88M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $3.05M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $4.32M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $1.92M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $1.73M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $4.26M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.59M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $5.12M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $7.58M 10-K · filed 2025-03-12 | |
| 2023-09-30 | $4.55M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.84M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $5.40M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $11.45M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $13.25M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $19.41M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $23.50M 10-Q · filed 2022-07-01 | |
| 2021-12-31 | $16.98M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $24.38M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $50.16M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $8.41M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.63M 10-K/A · filed 2022-07-01 | $1.63M 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |